- Details
- Description
-
Packaging Size1 Bottle/Box
-
Strength20mg/1ml
-
CompositonTocilizumab (托珠单抗)
-
TreatmentVarious inflammatory autoimmune conditions
-
FormInjection
-
BrandTofidence (施瑞立)
-
Quantity Unit80mg/4ml/Box,400mg/20ml/Box
-
ManufacturerBio-Thera Solutions,China
Tofidence® (Tocilizumab-bavi) sold under the brand name 施瑞立® in china, is a monoclonal antibody that binds to interlukin-6 receptors and is used to treat various inflammatory autoimmune conditions, including rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis.
Oct. 8, 2023,Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets, announced that its partner Biogen recently received notification from the United States Food and Drug Administration (FDA) on the approval of TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA.